I graduated from the University of California, Davis in 2014 with a Bachelor of Science in Biotechnology and a minor in Philosophy. As an undergraduate, I worked in the laboratory of Dr. Elizabeth Mitcham studying transcriptional regulation in ripening pears. Following graduation, I worked at Genentech as a biologics manufacturing technician and found an interest in cancer drug development. From 2016-2020, I worked at Five Prime Therapeutics as a research associate, first in the Molecular Biology department under the supervision of Dr. Elizabeth Bosch and then as part of the Immuno-Oncology Discovery department under the supervision of Dr. Art Brace and Dr. Andrew Rankin. I contributed to several early discovery programs, including mechanistic studies and antibody characterization for a novel immune checkpoint molecule in collaboration with Bristol-Myers Squibb and a novel tumor-expressed receptor that can be directly targeted to arrest cell proliferation.
I joined the University of Michigan in 2020 as a rotating graduate student in the Program for Biomedical Sciences (PIBS). I am now part of the Cancer Biology Program and a student in the lab of Dr. Megan Weivoda, where I am researching senescence and tumorigenesis in the bone marrow microenvironment.
In my free time, I enjoy baking cakes, hiking, running, and board gaming. I am also a big fan of escape rooms, with over 60 successful escapes so far (and hopefully more to add in Michigan).